Publication:
Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context.

dc.contributor.authorRivera, Patricia
dc.contributor.authorBindila, Laura
dc.contributor.authorPastor, Antoni
dc.contributor.authorPérez-Martín, Margarita
dc.contributor.authorPavón, Francisco J
dc.contributor.authorSerrano, Antonia
dc.contributor.authorde la Torre, Rafael
dc.contributor.authorLutz, Beat
dc.contributor.authorRodríguez de Fonseca, Fernando
dc.contributor.authorSuárez, Juan
dc.contributor.authoraffiliation[Rivera,P; Pavón,FJ; Serrano,A; Rodríguez de Fonseca,F; Suárez,J] UGC Salud Mental, Instituto de Investigación Biomédica (IBIMA), Universidad de Málaga-Hospital Universitario Regional de Málaga, Málaga, Spain. [Rivera,P; Pavón,FJ; Serrano,A; de la Torre,R; Rodríguez de Fonseca,F; Suárez,J] CIBER OBN, Instituto de Salud Carlos III, Madrid, Spain. [Bindila,L, Lutz,B] Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg-University of Mainz, Mainz, Germany. [Pastor,A; de la Torre,R] Institut Hospital del Mar d'Investigacions Mediques, Barcelona, Spain. [Pastor,A] Facultat de Medicina, Universitat Autonoma de Barcelona, Barcelona, Spain. [Pérez-Martín,M] Departamento de Biología Celular, Genética y Fisiología, Instituto de Investigación Biomédica (IBIMA), Universidad de Málaga, Málaga, Spain. [de la Torre, R] Facultat de Ciencies de la Salut i de la Vida, Universitat Pompeu Fabra (CEXS-UPF), Barcelona, Spain.es
dc.contributor.funderGrant sponsor: 7th Framework Programme of European Union; Grant number: HEALTH-F2-2008-223713, REPROBESITY to FR and BL; Grant sponsor: Ministerio de Ciencia e Innovación; Grant numbers: SAF2010-19087, SAF 2010-20521; Grant sponsor: Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, UE-ERDF; Grant number: CP12/03109; Grant sponsor: Red de Trastornos Adictivos; Grant numbers: RD12/0028/0001, RD12/0028/0009; Grant sponsor: CIBERobn; Grant sponsor: Plan Nacional Sobre Drogas, Ministerio de Sanidad y Consumo; Grant number: PNSD2010/143; Grant sponsor: Consejería de Economía, Innovación y Ciencia, Junta de Andalucía, UE/ERDF; Grant numbers: CTS-433, P-11-CVI-07637; Grant sponsor: Consejería de Salud, Junta de Andalucía; Grant numbers: PI0232/2008, PI0029/2008, SAS111224; Grant sponsor: Fundació La Marató de TV3; Grant number: 386/C/2011; Grant sponsor: German Research Foundation DFG; Grant number: FOR629, project CP2 to BL. JS, FP, and AS hold “Miguel Servet” research contracts from the National System of Health, ISCIII (Grant numbers: CP12/03109, CP14/00212, CP14/00173 respectively).
dc.date.accessioned2016-08-09T10:22:38Z
dc.date.available2016-08-09T10:22:38Z
dc.date.issued2015-03-27
dc.descriptionJournal Article;es
dc.description.abstractEndocannabinoids participate in the control of neurogenesis, neural cell death and gliosis. The pharmacological effect of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which limits the endocannabinoid degradation, was investigated in the present study. Cell proliferation (phospho-H3(+) or BrdU(+) cells) of the main adult neurogenic zones as well as apoptosis (cleaved caspase-3(+)), astroglia (GFAP(+)), and microglia (Iba1(+) cells) were analyzed in the hippocampus, hypothalamus and striatum of rats intraperitoneally treated with URB597 (0.3 mg/kg/day) at one dose/4-days resting or 5 doses (1 dose/day). Repeated URB597 treatment increased the plasma levels of the N-acylethanolamines oleoylethanolamide, palmitoylethanolamide and arachidonoylethanolamine, reduced the plasma levels of glucose, triglycerides and cholesterol, and induced a transitory body weight decrease. The hippocampi of repeated URB597-treated rats showed a reduced number of phospho-H3(+) and BrdU(+) subgranular cells as well as GFAP(+), Iba1(+) and cleaved caspase-3(+) cells, which was accompanied with decreased hippocampal expression of the cannabinoid CB1 receptor gene Cnr1 and Faah. In the hypothalami of these rats, the number of phospho-H3(+), GFAP(+) and 3-weeks-old BrdU(+) cells was specifically decreased. The reduced striatal expression of CB1 receptor in repeated URB597-treated rats was only associated with a reduced apoptosis. In contrast, the striatum of acute URB597-treated rats showed an increased number of subventricular proliferative, astroglial and apoptotic cells, which was accompanied with increased Faah expression. Main results indicated that FAAH inhibitor URB597 decreased neural proliferation, glia and apoptosis in a brain region-dependent manner, which were coupled to local changes in Faah and/or Cnr1 expression and a negative energy context.es
dc.description.versionYeses
dc.identifier.citationRivera P, Bindila L, Pastor A, Pérez-Martín M, Pavón FJ, Serrano A, et al. Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context. Front Cell Neurosci. 2015; 9:98es
dc.identifier.doi10.3389/fncel.2015.00098
dc.identifier.essn1662-5102
dc.identifier.pmcPMC4375993
dc.identifier.pmid25870539
dc.identifier.urihttp://hdl.handle.net/10668/2340
dc.journal.titleFrontiers in Cellular Neuroscience
dc.language.isoen
dc.publisherFrontiers Mediaes
dc.relation.publisherversionhttp://journal.frontiersin.org/article/10.3389/fncel.2015.00098/fulles
dc.rights.accessRightsopen access
dc.subjectURB597es
dc.subjectFAAHes
dc.subjectCannabinoidses
dc.subjectEnergy metabolismes
dc.subjectNeurogenesises
dc.subjectGliosises
dc.subjectBromodesoxiuridinaes
dc.subjectCannabinoideses
dc.subjectCarbamatoses
dc.subjectCaspasa 3es
dc.subjectMuerte celulares
dc.subjectProliferación celulares
dc.subjectColesteroles
dc.subjectEndocannabinoideses
dc.subjectEtanolaminases
dc.subjectGlucosaes
dc.subjectHipocampoes
dc.subjectHipotálamoes
dc.subjectMicroglíaes
dc.subjectÁcidos oléicoses
dc.subjectÁcidos palmíticoses
dc.subjectRatases
dc.subjectReceptor cannabinoide CB1es
dc.subjectTriglicéridoses
dc.subjectAmidohidrolasases
dc.subjectApoptosises
dc.subjectAstrocitoses
dc.subjectBenzamidases
dc.subjectPeso corporales
dc.subjectCerebroes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Amidohydrolaseses
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animalses
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Death::Apoptosises
dc.subject.meshMedical Subject Headings::Anatomy::Cells::Neuroglia::Astrocyteses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Benzamideses
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Physiological Phenomena::Body Constitution::Body Weights and Measures::Body Size::Body Weightes
dc.subject.meshMedical Subject Headings::Anatomy::Nervous System::Central Nervous System::Braines
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleosides::Deoxyribonucleosides::Deoxyuridine::Bromodeoxyuridinees
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Terpenes::Cannabinoidses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Carboxylic Acids::Acids, Acyclic::Carbamateses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Intracellular Signaling Peptides and Proteins::Apoptosis Regulatory Proteins::Caspaseses
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Deathes
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Growth Processes::Cell Proliferationes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Steroids::Cholestanes::Cholestenes::Cholesteroles
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Neurotransmitter Agents::Endocannabinoidses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amines::Amino Alcohols::Ethanolamineses
dc.subject.meshMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Gliosises
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Carbohydrates::Monosaccharides::Hexoses::Glucosees
dc.subject.meshMedical Subject Headings::Anatomy::Nervous System::Central Nervous System::Brain::Limbic System::Hippocampuses
dc.subject.meshMedical Subject Headings::Anatomy::Nervous System::Central Nervous System::Brain::Limbic System::Hypothalamuses
dc.subject.meshMedical Subject Headings::Anatomy::Nervous System::Neuroglia::Microgliaes
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Differentiation::Neurogenesises
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids, Unsaturated::Fatty Acids, Monounsaturated::Oleic Acidses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Fatty Acids::Palmitic Acidses
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Ratses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, G-Protein-Coupled::Receptors, Cannabinoid::Receptor, Cannabinoid, CB1es
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Glycerides::Triglycerideses
dc.titlePharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context.es
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 4 of 4
Loading...
Thumbnail Image
Name:
RiveraP_PharmacologicalBlockade.pdf
Size:
7.84 MB
Format:
Adobe Portable Document Format
Description:
Artículo publicado
Loading...
Thumbnail Image
Name:
RiveraP_PharmacologicalBlockadeSupplementaryMaterials.pdf
Size:
34.48 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Materials
Loading...
Thumbnail Image
Name:
RiveraP_PharmacologicalBlockade_Image1.tif
Size:
6.74 MB
Format:
Tag Image File Format
Description:
Image1
Loading...
Thumbnail Image
Name:
RiveraP_PharmacologicalBlockade_Image2.tif
Size:
1.46 MB
Format:
Tag Image File Format
Description:
Image2